Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Fagerberg

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
European Journal of Clinical Investigation|November 17, 2009
15-Lipoxygenase-2 is expressed in macrophages in human carotid plaques and regulated by hypoxia-inducible factor-1alphaL M Hultén, F J Olson, H Aberg, et al.
Clinical Chemistry|April 1, 1990
Thyrotoxic atrial fibrillation: an underdiagnosed or overdiagnosed condition?B Fagerberg, G Lindstedt, S O Strömblad, et al.
Diabetologia|January 19, 2012
Clinical dyslipidaemia is associated with changes in the lipid composition and inflammatory properties of apolipoprotein-B-containing lipoproteins from women with type 2 diabetesM Ståhlman, H T Pham, M Adiels, et al.
Lakartidningen|December 18, 1998
[Study and treatment of heart failure require new approaches. Natriuretic peptides can be safe and simple diagnostic and outcome measures]G Lindstedt, C H Bergh, K Caidahl, et al.
American Heart Journal|August 30, 2001
Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trialH Wedel, D Demets, P Deedwania, et al.
Diabetologia|July 8, 2005
Tesaglitazar, a novel dual peroxisome proliferator-activated receptor alpha/gamma agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic populationB Fagerberg, S Edwards, T Halmos, et al.
JAMA|March 14, 2000
Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study GroupA Hjalmarson, S Goldstein, B Fagerberg, et al.
Journal of Internal Medicine|June 23, 2015
The Swedish CArdioPulmonary BioImage Study: objectives and designG Bergström, G Berglund, A Blomberg, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
European Journal of Clinical Investigation|November 17, 2009
15-Lipoxygenase-2 is expressed in macrophages in human carotid plaques and regulated by hypoxia-inducible factor-1alphaL M Hultén, F J Olson, H Aberg, et al.
Clinical Chemistry|April 1, 1990
Thyrotoxic atrial fibrillation: an underdiagnosed or overdiagnosed condition?B Fagerberg, G Lindstedt, S O Strömblad, et al.
Diabetologia|January 19, 2012
Clinical dyslipidaemia is associated with changes in the lipid composition and inflammatory properties of apolipoprotein-B-containing lipoproteins from women with type 2 diabetesM Ståhlman, H T Pham, M Adiels, et al.
Lakartidningen|December 18, 1998
[Study and treatment of heart failure require new approaches. Natriuretic peptides can be safe and simple diagnostic and outcome measures]G Lindstedt, C H Bergh, K Caidahl, et al.
American Heart Journal|August 30, 2001
Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trialH Wedel, D Demets, P Deedwania, et al.
Diabetologia|July 8, 2005
Tesaglitazar, a novel dual peroxisome proliferator-activated receptor alpha/gamma agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic populationB Fagerberg, S Edwards, T Halmos, et al.
JAMA|March 14, 2000
Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study GroupA Hjalmarson, S Goldstein, B Fagerberg, et al.
Journal of Internal Medicine|June 23, 2015
The Swedish CArdioPulmonary BioImage Study: objectives and designG Bergström, G Berglund, A Blomberg, et al.
Pageof 13